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OBJECTIVES: Perfusion abnormalities are frequently seen in Single Photon Emission Computed Tomography
(SPECT) when a left bundle branch block is present. A few studies have shown decreased coronary flow reserve
in the left anterior descending territory, regardless of the presence of coronary artery disease.
OBJECTIVE: We sought to investigate rubidium-82 (82Rb) positron emission tomography imaging in the
assessment of myocardial blood flow and coronary flow reserve in patients with left bundle branch block.
METHODS: Thirty-eight patients with left bundle branch block (GI), median age 63.5 years, 22 (58%) female,
12 with coronary artery disease (X70%; GI-A) and 26 with no evidence of significant coronary artery disease
(GI-B), underwent rest-dipyridamole stress 82Rb-positron emission tomography with absolute quantitative flow
measurements using Cedars-Sinai software (mL/min/g). The relative myocardial perfusion and left ventricular
ejection fraction were assessed in 17 segments. These parameters were compared with those obtained from
30 patients with normal 82Rb-positron emission tomography studies and without left bundle branch block (GII).
RESULTS: Stress myocardial blood flow and coronary flow reserve were significantly lower in GI than in GII
(po0.05). The comparison of coronary flow reserve between GI-A and GI-B showed that it was different from
the global coronary flow reserve (po0.05) and the stress flow was significantly lower in the anterior than in the
septal wall for both groups. Perfusion abnormalities were more prevalent in GI-A (p=0.06) and the left
ventricular ejection fraction was not different between GI-A and GI-B, whereas it was lower in GI than in GII
(po0.001).
CONCLUSION: The data confirm that patients with left bundle branch block had decreased myocardial blood
flow and coronary flow reserve and coronary flow reserve assessed by 82Rb-positron emission tomography
imaging may be useful in identifying coronary artery disease in patients with left bundle branch block.
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Noninvasive diagnosis of coronary artery disease (CAD)
in left bundle branch block (LBBB) patients is a clinical and
methodological dilemma because septal perfusion abnorm-
alities have been demonstrated by myocardial perfusion
scintigraphy (gated-SPECT) even in the absence of CAD (1-8).
Some evidence has been published that indicates that there is
decreased coronary flow reserve (CFR) in the left anterior
descending (LAD) territory, regardless of the presence of
CAD. However, few studies have investigated the clinical
significance of this finding.
Rubidium-82 (82Rb) positron emission tomography (PET)
stress myocardial perfusion has emerged in the clinical
setting as a noninvasive imaging method for diagnosis and
risk-stratification that has several advantages compared to
Single Photon Emission Computed Tomography (SPECT). In
addition to assessing myocardial perfusion, wall motion and
left ventricular function, 82Rb-PET can quantify global and
regional myocardial blood flow (MBF) during both rest and
stress, and can also measure CFR, which is important for the
clinical management of patients with CAD (9,10).
Hirzel et al. (3) evaluated thallium-201 uptake and made
regional MBF measurements using radioactive microspheresDOI: 10.6061/clinics/2015(11)02
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in dogs with pacing-induced LBBB. The septal thallium-201
uptake and myocardial flow were significantly decreased
compared to that in the lateral wall, which showed that the
coronary flow to the septum is limited due to the deranged
contraction, i.e., the concept of functional ischemia.
In another invasive study using cardiac catheterization,
which evaluated CFR with adenosine in 13 patients with
LBBB and normal coronary arteries, Skalidis et al. (11) found
a longer time to maximum peak diastolic flow velocity than
that in controls. Furthermore, the CFR was significantly
lower in the LAD territory than in the right coronary artery
(RCA). The reduced CFR was associated with the presence of
scintigraphic perfusion abnormalities.
Coronary flow is dependent on both the epicardial vessel and
microvascular flow properties (12) and therefore, it is unclear
whether LBBB is associated with reduced CFR. Thus, we aimed
to evaluate the influence of LBBB on MBF, dipyridamole stress
MBF and CFR, as measured with 82Rb-PET.
’ MATERIALS AND METHODS
The study was performed at the Department of Nuclear
Medicine and Molecular Imaging of the Heart Institute of the
University of São Paulo Medical School and was approved
by the institutional ethics review board.
Study Design
From February to October 2013, 665 consecutive patients,
who were referred for dipyridamole-stress gated-SPECT for
the evaluation of known or suspected CAD, underwent 82Rb-
PET. Of the 51 patients with ECG evidence of LBBB who
were defined according to standard criteria (QRS X120 ms),
38 were selected (Group I - GI) who met the inclusion
criteria: LBBB and sinus rhythm. The median age was 63.5
years, range 58-68 years and 22 were women (58%). Patients
with unstable angina, recent myocardial infarction, pace-
maker rhythm and atrial fibrillation or flutter were excluded
from GI. In addition, we selected 30 patients without LBBB
(Group II - GII), who were free from known CAD and had
normal 82Rb-PET studies (including perfusion, function
and blood flow measurements), and matched them based
on the same clinical risk factors that are associated with
reduced absolute quantitative flow measurements (13,14).
The median age was 59.5 years (range 53-65 years) and
17 were women (57%).
Assessment of CAD
In a subset of patients, a request to perform a coronary
anatomy assessment was made by the patient’s doctor.
Therefore, a cardiac catheterization or coronary computed
tomography angiography (CTA) (15) was performed in
31 patients with LBBB. A significant coronary stenosis was
defined as X70% luminal narrowing in one or more vessels
(GI-A, n=12). Based on a finding of no significant stenosis
and a normal 82Rb-PET perfusion study, patients were
categorized into a subgroup with LBBB and no CAD (GI-B,
n=26).
Myocardial Perfusion 82Rb-PET Imaging Protocol
The patients were instructed to fast for 4 h, abstain from
caffeine and cigarettes for 24 h and theophyllines for 36 h,
and discontinue beta-blocker or calcium-channel blocker
medications for 3 days and long-acting nitrates for 6 hours
before the study.
Cardiac PET was performed using a Gemini-TOF 64-slice
system (Philips Medical Systems, Cleveland, Ohio, USA).
Resting images were acquired using a 3-D list mode
acquisition over 8 min, after a square wave intravenous
injection of 82Rb (10 MBq/kg; Jubilant DraxImage) over a
60-second interval.
Dipyridamole was infused intravenously (0.56 mg/kg)
over four minutes and the same 82Rb activity was adminis-
tered four minutes later. Stress images were acquired and
processed for the resting scan. The symptoms were treated
with intravenous aminophylline after the end of image
acquisition.
Before rest and after stress, 82Rb-PET image acquisitions
with two low-dose CT-based attenuation corrections for PET
transmission scans were performed (120 kV; 115 mAs; and
0.435 pitch), after a normal end-expiration. The estimated
effective radiation dose from the complete PET study (rest/
dipyridamole 82Rb and 2 CT attenuation corrections) was
3.0 mSv (16).
Image Processing
Fused CT and emission images were visually evaluated for
alignment by an experienced technologist and, if necessary,
corrected by manual 3-D translation. The images were
reconstructed using a 3-dimensional row-action maximum
likelihood algorithm (3-D-RAMLA), with 3 iterations/33
subsets and a medium filter. The entire 8 min of emission
data was binned to form a dynamic image sequence (9 x 10 s,
3 30 s, 1 60 s and 2 120 s) for MBF quantification and
the last 6 min to form myocardial uptake and ECG-gated
images. The images were semi-automatically reoriented to
generate short-axis and vertical long-axis slices. The left
ventricle ejection fraction (LVEF) was calculated from the rest
and stress images using 4D QGS (17) software, version
2012.2.
Quantitative MBF Measurements
The studies were processed in batch mode using QPET
(Cedars-Sinai, Los Angeles, California) to quantify MBF and
CFR. In brief, left ventricle (LV) contours were positioned
automatically with an algorithm that determines the LV
contours from the summed dynamic images data. The 3-D
cylindrical region (1 cm diameter, 2 cm length) for the LV
input function was automatically placed in the middle of the
valve plane and oriented along the long axis of the heart.
Dynamic myocardial samples were obtained from the polar
map by analyzing all of the time frames within the fixed LV
contour boundaries (18).
A standard 1-tissue compartment model was used to
quantify MBF, which includes regional uptake and clearance
parameters (K1 [mL/min/g of myocardial tissue] and k2
[min-1]), blood-to-myocardial spillover fraction and myocar-
dial partial-volume corrections. A previously calibrated 82Rb
extraction fraction was used to estimate MBF from K1 (19).
Stress and rest MBF were computed for each sample in the
polar map, and CFR was calculated as the ratio of stress/rest
MBF. Four basal slices were not used for flow analysis due to
low counts in the membranous septum. MBF in each
vascular territory was then obtained by averaging the polar
map segments in the regions of the LAD, RCA, and left
circumflex artery (LCX), according to the standard 17 segments
of the American Heart Association model (20) and correspond-
ing to the anterior, septal, lateral, inferior, and apical walls.
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Image Interpretation
Rest and stress uptake images were visually analyzed
using a 5-point score (0-normal; 1-mild uptake; 2-moderate;
3-severe and 4-no uptake) for relative myocardial perfusion
in 17 segments (20). We compared the GI-A and GI-B
patients considering the anterior and septal walls as
segments 1, 2, 7, 8, 13, and 14 and the lateral and inferior
walls as segments 3, 4, 5, 6, 9, 10, 11, 12, 15, and 16. Segment
17 was excluded in this analysis. Two experienced nuclear
physicians who were blinded to the patient data analyzed
the perfusion images. Summed stress scores (SSS), summed
rest scores (SRS) and summed difference scores (SDS) were
determined. An SSS X4 and/or SDS X2 were considered
perfusion abnormalities. A rest or stress LVEF o45% was
considered to be abnormal.
Statistical Analysis
Quantitative variables were expressed in medians (25%-75%
quartile), while qualitative variables were expressed in percen-
tages. Differences in the quantitative variables between GI
and GII were verified by t or Mann-Whitney tests conditioned
by the normality distribution assumption, which was checked
using the Anderson-Darling test and the assumption of
homogeneity of variances, which was established by the
Levene test. In turn, discrepancies among GI-A, GI-B and GII
were verified by ANOVA or Kruskal-Wallis tests, supported by
the assumptions of normality and homogeneity of variances.
Next, multiple comparisons relative to GI-A vs. GI-B and GI-B
vs. GII were performed using the parametric or nonparametric
Dunnett test (21).
Comparisons of the anterior or septal wall with the other
walls were evaluated using the paired nonparametric
Dunnett test (22). Finally, differences in the qualitative
variables were analyzed using the Fisher test. All of the
discrepancies were classified as statistically significant
considering a significance level at 5%. The calculations were
performed using the R package, version 3.1.1. (23).
Ethics
All of the procedures that were performed in studies that
involved human participants were in accordance with the
ethical standards of the institutional and national research
committee and with the 1964 Helsinki declaration and its
later amendments or comparable ethical standards. This
article does not contain any studies with animals performed
by any of the authors. Informed consent was obtained from
all individual participants included in the study.
’ RESULTS
Clinical and demographic characteristics
The patient demographics are summarized in Table 1. In
GI patients, 12 had CAD (32%, GI-A) with 2- or 3-vessel
disease in 67%, 1-vessel disease in 25% and a myocardial
bridge in 8%. Twenty-six patients (68%, GI-B) had normal
coronary arteries or o70% stenosis and normal 82Rb-PET
perfusion. The median ages were not significantly different
(GI vs. GII, p=1.00; GI-A vs. GI-B vs. GII, p=0.06). The female
gender was predominant in all groups. Furthermore, the
main clinical risk factors, such as hypertension, dyslipidemia
and diabetes, were also not significantly different between
the groups.
Quantitative MBF Measurements
Global and regional values in GI and GII are summarized
in Table 2. The stress flow and CFR were significantly lower
in GI than in GII in all of the walls (po0.001), whereas the
rest flow was lower only in the septal and apical walls
(p=0.02 and 0.01, respectively). A comparison of the anterior
or septal walls with the other walls in GI revealed that the
rest flow, stress flow and CFR were significantly lower in the
anterior wall and less so in the septal wall. However, the rest
and stress flows were also significantly lower in the septal
than in the inferior wall (Table 2). A comparison between
GI-A and GI-B did not show any significant flow differences,
except for the global CFR (p=0.05) and could identify CAD in
LBBB (Table 3). Moreover, GI-A and GI-B had significantly
lower stress flow in the anterior wall than in the septal wall.
Thus, flow in the anterior wall was more affected by LBBB
than that in the septal wall, independent of the presence of
CAD. CFR in the apical and lateral walls were lower in GI-B
than in GII, which could explain a pattern characteristic of
LBBB in the absence of CAD.
Myocardial Perfusion 82Rb-PET Imaging and
LV function
Twenty-four patients in GI (63%) had no significant
perfusion abnormalities and all patients in GII had normal
perfusion. Moreover, the perfusion abnormalities (SSS X4
and/or SDSX2) tended to be more prevalent in the presence
Table 1 - Comparison of demographic characteristics among groups.
GI (n=38) GI-A (n=12) GI-B (n=26) GII (n=30) p-value
Age (yrs) 63.5 (58.25 - 68) 65 (62 - 69.25) 63.5 (58 - 67.75) 59.5 (53 - 64.75) 0.06
BMI (kg/m2) 25.3 (23.45 - 28.7) 25.9 (24.75 - 28.58) 24.8 (22.8 - 28.7) 27.85 (25.12 - 29.37) 0.23
Female 58% 67% 54% 57% 0.76
FH of CAD 30% 33% 29% 8% 0.13
Hypertension 73% 83% 67% 73% 0.64
Diabetes 39% 58% 29% 29% 0.20
Dyslipidemia 61% 58% 62% 52% 0.83
Smoking 30% 50% 19% 16% 0.07
Prior MI 22% 58% 0% 0% o 0.001
Prior PCI 3% 8% 0% 0% 0.21
Prior CABG 6% 17% 0% 0% 0.04
CAD = coronary artery disease; BMI = body mass index; FH of CAD = family history of CAD; MI = myocardial infarction; PCI = percutaneous coronary
intervention; CABG = coronary artery bypass graft surgery.
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of CAD (GI-A vs. GI-B; p=0.06). We found statistically
significant differences between the groups when we con-
sidered perfusion abnormalities in the anterior and/or septal
walls (p=0.04) as well as in the inferior and/or lateral walls
(p=0.003) (Figure 1).
LVEF values and LV cavity volumes are summarized in
Tables 4 and 5. Twenty-five patients in GI (66%) had LV
dysfunction at rest and all of the GII subjects had normal
LVEF. There were significantly lower rest and stress LVEFs in
GI than in GII (po0.001), but no significant differences
between GI-A and GI-B (p=ns). However, GI-A had a high
prevalence of LVEF dysfunction (o45%) only during stress
(p=0.02).
’ DISCUSSION
An evolution in cardiovascular imaging with PET-CT
systems being incorporated into the clinical setting has been
occurring since the early 2000s. This trend is partially driven
by the fact that cardiac PET-CT offers a noninvasive method
to assess relative myocardial perfusion, LV function, MBF
and calcium score (15). The importance and independent
Table 2 - Results of global and regional 82Rb-PET myocardial blood flow measurements during stress and rest and CFR in GI and GII.
GI (n=38) GII (n=30) p-value
Stress (mL/min/g)
ANT 1.38 (1.07 - 1.99) 2.33 (1.74 - 3.01) o 0.001
SEP 1.75 (1.31 - 2.33) D 2.95 (2.23 - 3.39) o 0.001
APX 1.25 (0.96 - 1.90) 2.31 (1.87 - 2.75) o 0.001
LAT 1.68 (1.43 - 2.36) D 2.52 (2.03 - 3.04) o 0.001
INF 1.99 (1.48 - 2.95) wD 2.72 (2.17 - 3.49) 0.001
GLOBAL 1.64 (1.22 - 2.54) 2.54 (1.99 - 3.15) o 0.001
Rest (mL/min/g)
ANT 0.66 (0.54 - 0.94) 0.84 (0.64 - 0.98) 0.07
SEP 0.75 (0.62 - 1.04) D 0.94 (0.75 - 1.15) 0.02
APX 0.65 (0.57 - 0.95) 0.86 (0.66 - 1.08) 0.01
LAT 0.79 (0.62 - 0.97) D 0.86 (0.72 - 1.03) 0.18
INF 0.91 (0.68 - 1.13) wD 0.88 (0.70 - 1.21) 0.44
GLOBAL 0.74 (0.62 - 1.07) 0.86 (0.73 - 1.10) 0.11
Coronary Flow Reserve
ANT 2.15 (1.74 - 2.76) 2.75 (2.36 - 3.55) 0.003
SEP 2.48 (1.82 - 3.11) D 3.12 (2.62 - 3.46) 0.008
APX 1.94 (1.31 - 2.81) 2.74 (2.20 - 3.31) 0.001
LAT 2.30 (1.82 - 2.64) 2.96 (2.53 - 3.67) o 0.001
INF 2.44 (1.95 - 3.09) 3.17 (2.50 - 3.95) 0.005
GLOBAL 2.46 (1.86 - 2.82) 3.03 (2.46 - 3.72) 0.007
ANT = anterior wall; SEP = septal wall; APX = apical wall; LAT = lateral wall; INF = inferior wall.
wpo0.05 in a comparison between the septal and other walls in GI; Dpo0.05 in a comparison between the anterior and other walls in GI.
Table 3 - Results of the comparison of global and regional 82Rb-PET myocardial blood flow among groups.
Wall GI-A (n=12) GI-B (n=26) p-value~ GII (n=30) p-value*
Stress (mL/min/g)
ANT 1.16 (0.82 - 1.89) 1.48 (1.20 - 1.99) 0.53 2.33 (1.74 - 3.01) o 0.01
SEP 1.48 (1.15 - 2.29) D 1.88 (1.53 - 2.33) D 0.73 2.95 (2.23 - 3.39) o 0.01
APX 1.12 (0.76 - 1.73) 1.29 (1.09 - 1.90) 0.67 2.31 (1.87 - 2.75) o 0.01
LAT 1.70 (1.24 - 2.10) 1.65 (1.44 - 2.36) 0.96 2.52 (2.03 - 3.04) o 0.01
INF 1.92 (1.48 - 2.33) D 2.08 (1.51 - 2.95) wD 0.73 2.72 (2.17 - 3.49) 0.03
GLOBAL 1.56 (1.13 - 2.05) 1.75 (1.44 - 2.54) 0.51 2.54 (1.99 - 3.15) 0.01
Rest (mL/min/g)
ANT 0.72 (0.55 - 1.02) 0.66 (0.54 - 0.90) 0.28 0.84 (0.64 - 0.98) 0.28
SEP 0.74 (0.62 - 1.12) 0.75 (0.63 - 0.92) D 0.14 0.94 (0.75 - 1.15) 0.14
APX 0.72 (0.60 - 1.07) 0.64 (0.56 - 0.86) 0.45 0.86 (0.66 - 1.08) 0.02
LAT 0.86 (0.72 - 1.23) 0.68 (0.60 - 0.96) 0.10 0.86 (0.72 - 1.03) 0.10
INF 0.94 (0.77 - 1.27) wD 0.79 (0.64 - 1.05) D 0.50 0.88 (0.70 - 1.21) 0.50
GLOBAL 0.80 (0.66 - 1.11) 0.72 (0.62 - 1.04) 0.33 0.86 (0.73 - 1.10) 0.33
Coronary Flow Reserve
ANT 1.86 (1.18 - 2.49) 2.31 (1.98 - 2.76) 0.31 2.75 (2.36 - 3.55) 0.08
SEP 1.92 (1.31 - 2.64) 2.62 (2.13 - 3.16) D 0.16 3.12 (2.62 - 3.46) 0.21
APX 1.40 (1.14 - 1.98) 2.00 (1.57 - 2.96) 0.25 2.74 (2.20 - 3.31) 0.04
LAT 2.04 (1.10 - 2.41) 2.44 (1.90 - 2.66) 0.36 2.96 (2.53 - 3.67) 0.01
INF 2.05 (1.40 - 2.49) 2.77 (2.31 - 3.13) 0.09 3.17 (2.50 - 3.95) 0.20
GLOBAL 1.94 (1.20 - 2.58) 2.59 (2.16 - 2.95) 0.05 3.03 (2.46 - 3.72) 0.28
CAD = coronary artery disease; ANT = anterior wall; SEP = septal wall; APX = apical wall; LAT = lateral wall; INF = inferior wall.
~Comparison between GI-A and GI-B; * Comparison between GII and GI-B; w refers to the comparison between the septal and other walls in GI-B;
D refers to the comparison between the anterior and other walls in GI-A or in GI-B.
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prognostic values of MBF and CFR using 82Rb-PET, beyond
relative myocardial perfusion image interpretation, has
already been established. Worse patient outcomes and a
higher incidence of cardiac events (death and myocardial
infarction) have been demonstrated in cases with global CFR
o2 mL/min/g in patients with normal and abnormal
relative myocardial perfusion (24,25).
Despite the low prevalence of LBBB in the general
population (26), several studies have reported its frequent
association with heart disease. In the Framingham study, CAD
was found in 40% of LBBB patients and was associated with a
fourfold increase in the risk of cardiovascular mortality (27).
Dynamic alterations in the cardiac cycle produced by LBBB
are known: asynchrony of contraction in the ventricles;
reduction of LV diastolic time; abnormal septal motility; and
abnormal septal ejection fraction (3,4,28,29). Such alterations
confound the noninvasive diagnosis of CAD, especially with
the exercise gated-SPECT test (1,4-8,30-32). The mechanisms
that are responsible for abnormal findings may be associated
with functional ischemia (4,5,28) or abnormal CFR (3).
However, few studies have reported patterns in MBF and
CFR in LBBB, and they did not include patients with CAD.
A study by Masci et al. (33) evaluated a small group of patients
with dilated cardiomyopathy and LBBB with 2-[(18)F]fluoro-
2-deoxyglucose and (13)N-ammonia-PET. They did not
demonstrate significant differences in MBF and CFR between
patients with and without LBBB. However, the myocardial
glucose metabolic rate was lowest in the septum of LBBB
patients. In another study (34), 10 LBBB patients were
analyzed with 15O-water PET and the study results showed
that the septal/lateral MBF ratio was 19% lower than that in
the controls, as a result of functional alterations. Our study
assessed LBBB patients and showed that stress MBF as well
as CFR were significantly lower in all of the walls in a larger
LBBB population compared to the controls. We were careful
to compare 2 homogeneous populations that were matched
for the presence of primary clinical risk factors, which are
associated with reduced stress flow and CFR (13), because
coronary atherosclerosis is common in middle-aged people.
Our results confirm previous findings of reduced rest flow in
the anterior and septal walls, which demonstrates that LBBB
affects MBF and CFR, probably because of abnormal LV
activation and uncoordinated contractions (29). Another
confirmatory finding was that globally and for most of the
walls, CFR was abnormal in the presence of CAD (o2 mL/
min/g) (24), which demonstrates there is an incremental
influence of the presence of CAD on LBBB and CFR
measurement by 82Rb-PET that could aid in the identification
of CAD and risk-stratification of LBBB patients.
Our results suggest that resting MBF in the inferior wall
may not be influenced by the presence of LBBB (in GI-A
patients, stress MBF was lower in the anterior than in the
septal wall and even lower in the inferior wall). In GI-B
patients, stress and rest flow were also lower in the anterior
than in the septal and inferior walls. It appears that LBBB did
not interfere with the evaluation of MBF and CFR in the
inferior wall or the abnormal activation of the LV because
LBBB is more proximal (anterior and high septum areas),
sparing the inferior or even lateral walls, which are opposite
and more distal. In the presence of LBBB (both with and
without CAD), stress MBF was also lower in the anterior
than in the septal wall. The septal wall showed a smaller
MBF impairment than that in the anterior wall, which could
be explained by the fact that the septum is a less extensive
Figure 1 - Myocardial perfusion abnormalities were more
prevalent in GI-A than in GI-B (p=0.03), and 82Rb-PET myocardial
perfusion could discriminate between the groups in all LV
territories. All of the values are expressed in terms of the number
of patients. A = anterior; S = septal; I = inferior; L = lateral.
Table 4 - Results of the comparison of left ventricle ejection
fraction between GI and GII.
GI (n=38) GII (n=30) p-value
Stress LVEF (%) 43 (26 - 60) 74.5 (70 - 80.75) o 0.001
Rest LVEF (%) 39.5 (21 - 55) 68.5 (60 - 74) o 0.001
Stress ESV (ml) 84 (50 - 130) 24 (21 - 32) 0.07
Rest ESV (ml) 78.5 (37.25 - 129.25) 30 (21.25 - 39.25) o 0.001
Stress EDV (ml) 147 (98 - 185) 91 (82.25 - 105) o 0.001
Rest EDV (ml) 136 (80 - 176.75) 86.5 (73 - 97.5) 0.001
LVEF = left ventricular ejection fraction; ESV= end systolic volume; EDV = end
diastolic volume.
Table 5 - Results of the comparisons of left ventricular ejection fraction between GI-A, GI-B, and GII.
GI-A (n=12) GI-B (n=26) p-value~ GII (n=30) p-value*
Stress LVEF (%) 35 (24 - 42.5) 51.5 (26.5 - 61.5) 0.18 74.5 (70 - 80.75) o 0.01
Rest LVEF (%) 30.5 (22.75 - 41.75) 43 (21 - 56.75) 0.50 68.5 (60 - 74) o 0.01
Stress ESV (ml) 109 (72.5 - 166) 74.5 (47.5 - 121.5) 0.32 24 (21 - 32) o 0.01
Rest ESV (ml) 98 (70.25 - 151.5) 69 (26 - 124.75) 0.25 30 (21.25 - 39.25) o 0.01
Stress EDV (ml) 171 (126 - 214.5) 137.5 (96.5 - 173.75) 0.26 91 (82.25 - 105) 0.03
Rest EDV (ml) 153 (96.75 - 193.25) 119 (58 - 160) 0.25 86.5 (73 - 97.5) 0.24
~ refers to the comparison between GI-A vs. GI-B; * refers to the comparison between GII vs. GI-B.
LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; ESV= end systolic volume; EDV = end diastolic volume.
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area compared to others and thus, MBF may have a lower
expression or be underestimated in a quantitative evaluation.
Our study also suggests that 82Rb-PET relative myocardial
perfusion could discriminate between LBBB patients with
and without CAD, even when considering the LAD territory
alone. Perfusion abnormalities were more prevalent in the
presence of CAD. Although anterior and septal abnormal-
ities have been described in most similar studies in the
absence of CAD, perfusion abnormalities may also result
from technical imaging issues (e.g., partial volume effect
and attenuation artifacts - mainly with SPECT), functional
ischemia, CFR alterations caused by the LV dynamic
asynchrony, or because of subclinical myocardial disease
(4,5,28).
Rest and stress LVEFs in LBBB patients were also lower
than those in GII. As expected, GI-B had less LV dysfunction
than GI-A at stress and it was associated with CAD.
Furthermore, GI-A on average had a lower LVEF response
to stress compared to GI-B. Nevertheless, even in the absence
of established CAD, patients with LBBB demonstrated a
decreased LV reserve and might not respond appropriately to
stress (35).
The mechanisms that underlie the reduced MBF and CFR
in nonischemic cardiomyopathy can include endothelial
dysfunction, macro- and microvascular obstruction, vascular
remodeling and extravascular compressive forces (36,37),
which could have contributed to reduced MBF, CFR and
even LV dysfunction in GI-B. A recent study demonstrated
that impairment in CFR is common in both ischemic and
nonischemic cardiomyopathy. CFR p1.65 mL/min/g by
PET imaging in this population was associated with higher
major adverse cardiovascular events (38).
Thus, the presence of CAD had a profound effect on CFR
and also on traditional relative myocardial perfusion and LV
function measures, with a higher prevalence of perfusion and
LVEF abnormalities in GI-A. There was a detrimental
influence of LBBB over ventricular dynamics, independent
of the presence of CAD. These functional abnormalities may
be associated with abnormal MBF, perfusion, and function.
According to our data, an advantage of using 82Rb-PET is
that it could provide additional information for the assess-
ment of CAD in LBBB patients.
Study limitations
Our study has some limitations. Despite the fact that
82Rb-PET has several advantages compared with SPECT
studies, one disadvantage is the inability to perform
82Rb-PET in association with exercise stress tests, due to the
short half-life of the tracer. However, in LBBB, pharmacolo-
gical stress is preferable to exercise perfusion imaging for
both diagnosis and risk stratification (20).
This was a single-center observational study that was
performed with a select population of LBBB patients. Thus,
its results may not be applicable to all such patients because
the great diversity of clinical situations in which LBBB can be
present may yield different results. Moreover, cardiac
catheterization or CTA were not available in all LBBB
patients. Usually, the absence of relative perfusion defects
in PET-CT studies is associated with non-significant CAD
(39). Finally, the high prevalence of LV dysfunction in the
absence of CAD might be related to cardiomyopathy, but
alterations in MBF and CFR on 82Rb-PET in these patients
were expected even in the absence of CAD (38).
In the present study, we showed that LBBB patients who
were assessed by 82Rb-PET have decreased MBF and CFR in
all LV territories. Moreover, these measures are important
diagnostic tools for patients with LBBB and suspected CAD,
which might be identified with a CFR evaluation.
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